Lumakras Sales A Highlight Of Amgen’s Mixed Q3

Aimovig Down Sequentially And Year-Over-Year

 
• By Mandy Jackson
  
Amgen logo at biopharmaceutical company office in South San Francisco
Amgen saw improved Prolia sales but Aimovig underperformed • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip